We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
5ec9
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5ec9' size='340' side='right'caption='[[5ec9]], [[Resolution|resolution]] 2.30Å' scene=''> | <StructureSection load='5ec9' size='340' side='right'caption='[[5ec9]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5ec9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[5ec9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EC9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5EC9 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5LO:4-[(11S,15R)-4,4,7,7-TETRAMETHYL-16-OXATETRACYCLO[8.6.0.03,8.011,15]HEXADECA-1(10),2,8-TRIEN-11-YL]BENZOIC+ACID'>5LO</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5LO:4-[(11S,15R)-4,4,7,7-TETRAMETHYL-16-OXATETRACYCLO[8.6.0.03,8.011,15]HEXADECA-1(10),2,8-TRIEN-11-YL]BENZOIC+ACID'>5LO</scene></td></tr> | |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ec9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ec9 OCA], [https://pdbe.org/5ec9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ec9 RCSB], [https://www.ebi.ac.uk/pdbsum/5ec9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ec9 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ec9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ec9 OCA], [https://pdbe.org/5ec9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ec9 RCSB], [https://www.ebi.ac.uk/pdbsum/5ec9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ec9 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/RXRA_HUMAN RXRA_HUMAN] Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes.<ref>PMID:10195690</ref> <ref>PMID:11162439</ref> <ref>PMID:11915042</ref> <ref>PMID:20215566</ref> | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 26: | Line 26: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Brunsveld | + | [[Category: Brunsveld L]] |
| - | [[Category: Burnstein | + | [[Category: Burnstein ES]] |
| - | [[Category: Leysen | + | [[Category: Leysen S]] |
| - | [[Category: Ma | + | [[Category: Ma JN]] |
| - | [[Category: Olsson | + | [[Category: Olsson R]] |
| - | [[Category: Ottmann | + | [[Category: Ottmann C]] |
| - | [[Category: Schafer | + | [[Category: Schafer A]] |
| - | [[Category: Scheepstra | + | [[Category: Scheepstra M]] |
| - | [[Category: Sunden | + | [[Category: Sunden R]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and a fragment of the coactivator TIF2
| |||||||||||
Categories: Homo sapiens | Large Structures | Brunsveld L | Burnstein ES | Leysen S | Ma JN | Olsson R | Ottmann C | Schafer A | Scheepstra M | Sunden R
